Skip to content
Screener

Ryan Specialty Holdings RYAN Contingent consideration fair value adjustment

Contingent consideration fair value adjustment at other companies

Insmed logo
InsmedINSM
-$46.96M-357%
Blackrock logo
BlackrockBLK
$180M+2,100%
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$622K—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$0—

Segments

By segment

See full
Reporting Segment$27.29M+294%

Other financials

Income statement

See full
Revenue$795.2M+15.2%
Operating income$94.6M-5.6%
Net income$17.6M+164%
EPS (diluted)$0.12-33.8%

Balance sheet

See full
Cash & equivalents$1.5B+13.2%
Total debt$3.8B-2.3%
Total equity$636.2M+17.3%
Total assets$11.0B+11.3%

Cash flow

See full
Operating cash flow-$167.4M-17.2%
CapEx--100%
Free cash flow-$167.4M-16.7%

Valuation

See full
Market cap$5.76B-21.6%
Enterprise value$8.05B-15.1%
P/E53×-79.0×
P/S1.8×-0.8×

Profitability

See full
Operating margin15.5%-1.7pp
Net margin3.4%+1.5pp
FCF margin19.5%+1.2pp

Returns & leverage

See full
Return on equity18.4%+9.2pp
Debt / equity5.9×-1.2×
Current ratio1×0.0×